Medical Schools Push Back on ‘March-In’ Rights Plan to Lower Drug Prices

Source link :

Key stakeholders from academia and medicine are pushing back on a Biden administration proposal that would leverage “march-in rights” in an effort to rein in unreasonably priced drugs developed with the support of taxpayer dollars. In a letter sent last week to the National Institute of Standards and Technology (NIST) — the authors of the […]

Author : News Health

Publish date : 2024-02-08 16:54:54

Copyright for syndicated content belongs to the linked Source.